Oflafix OZ tablet - Astemax BiotechOflafix OZ tablet - Astemax Biotech

Oflafix OZ tablet

Introduction

Oflafix OZ is Astemax Biotech’s high-quality WHO-GMP certified tablet combining Ofloxacin 200 mg and Ornidazole 500 mg, targeting mixed bacterial and protozoal infections effectively.

Key Ingredients

Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV to prevent DNA replication and kill Gram-positive/negative pathogens. Ornidazole, a nitroimidazole, damages protozoal and anaerobic bacterial DNA, leading to cell death for comprehensive coverage.

Health Benefits

This combination treats diarrhea, dysentery, gynecological infections, UTIs, respiratory tract infections, and skin infections caused by mixed aerobes/anaerobes/protozoa, providing rapid symptom relief and high cure rates in gastrointestinal and pelvic cases.

Take 1 tablet twice daily after meals for 5-10 days, completing the full course; adjust for children or severity under medical guidance.

Usage Precautions

Avoid in quinolone allergy, pregnancy (especially first trimester), or children under 8; monitor for nausea, dizziness, or photosensitivity. Astemax’s GMP standards ensure purity and stability.

Get a Quote
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors